Catalyst Wire Dossier Catalyst Wire Dossier

Fluvastatin sodium extended-release tablets 80 mg

fluvastatin · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fluvastatin sodium extended-release tablets 80 mg, covering 2014-06-11 to 2014-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia [Phase 4]

See pricing